Association of tumor PD-L1 expression and immune biomarkers with clinical activity in patients (pts) with advanced solid tumors treated with nivolumab (anti-PD-1; BMS-936558; ONO-4538).

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Grosso, J; Horak, CE; Inzunza, D; Cardona, DM; Simon, JS; Gupta, AK; Sankar, V; Park, J-S; Kollia, G; Taube, JM; Anders, R; Jure-Kunkel, M; Novotny, J; Taylor, CR; Zhang, X; Phillips, T; Simmons, P; Cogswell, J

Published Date

  • May 20, 2013

Published In

Volume / Issue

  • 31 / 15

Published By


  • 2

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Conference Location

  • Chicago, IL

Conference Start Date

  • May 31, 2013

Conference End Date

  • June 4, 2013